Targeting the heat shock protein 90 dimer with dimeric inhibitors.

The design, synthesis, and biological evaluation of conformationally constrained coumermycin A1 analogues are reported. Compounds were evaluated against both breast cancer (SKBr3 and MCF7) and prostate cancer (PC3 mm2, A549, and HT29) cell lines. Non-noviosylated coumermycin A1 analogues that manifest potent antiproliferative activity resulting from Hsp90 inhibition are provided, wherein replacement of the stereochemically complex noviose sugar with readily available piperidine rings resulted in ∼100 fold increase in antiproliferative activities as compared to coumermycin A1, producing small molecule Hsp90 inhibitors that exhibit nanomolar activities.

[1]  T. Chakraborty,et al.  Studies directed toward the synthesis of glycopeptide antibiotic teicoplanin: first synthesis of the N-terminal 14-membered ring , 1992 .

[2]  B. Blagg,et al.  Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. , 2008, The Journal of organic chemistry.

[3]  D. Schmatz,et al.  Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II. , 2007, European journal of medicinal chemistry.

[4]  Huiping Zhao,et al.  Cytotoxic sugar analogues of an optimized novobiocin scaffold , 2010 .

[5]  L. Neckers,et al.  A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion , 2008, Oncogene.

[6]  Xiao Ming Yu,et al.  Syntheses of photolabile novobiocin analogues. , 2004, Bioorganic & medicinal chemistry letters.

[7]  D. Schmatz,et al.  Synthesis and biological activity of imidazopyridine anticoccidial agents: part I. , 2007, European journal of medicinal chemistry.

[8]  B. Blagg,et al.  Radester, a novel inhibitor of the Hsp90 protein folding machinery. , 2005, Organic letters.

[9]  H. Brunner,et al.  Asymmetrische Katalysen, IL: Optisch aktive Binaphthylderivate — Synthese und Einsatz in Übergangsmetallkatalysatoren , 1989 .

[10]  B. Blagg,et al.  To fold or not to fold: modulation and consequences of Hsp90 inhibition. , 2009, Future medicinal chemistry.

[11]  Carol A. Mulrooney,et al.  Perylenequinone natural products: total syntheses of the diastereomers (+)-phleichrome and (+)-calphostin D by assembly of centrochiral and axial chiral fragments. , 2010, The Journal of organic chemistry.

[12]  H. Hopf,et al.  Paracyclophanes: Extending the Bridges. Synthesis , 2009 .

[13]  M. Winters,et al.  Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth , 1982, Antimicrobial Agents and Chemotherapy.

[14]  B. Blagg,et al.  Hsp90: a novel target for the disruption of multiple signaling cascades. , 2007, Current cancer drug targets.

[15]  B. Blagg,et al.  Synthesis and Evaluation of Noviose Replacements on Novobiocin that Manifest Anti-proliferative Activity. , 2010, ACS medicinal chemistry letters.

[16]  B. Blagg,et al.  Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. , 2011, Journal of medicinal chemistry.

[17]  Anthony Maxwell,et al.  Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90. , 2006, Journal of the American Chemical Society.

[18]  G. Giaccone,et al.  Update on Hsp90 inhibitors in clinical trial. , 2009, Current topics in medicinal chemistry.

[19]  R. Scannevin,et al.  Heat shock protein 90: inhibitors in clinical trials. , 2010, Journal of medicinal chemistry.

[20]  R. Middleton,et al.  The intramolecular Heck reaction , 1997 .

[21]  H. Gronemeyer,et al.  C3 Halogen and C8′′ Substituents on Stilbene Arotinoids Modulate Retinoic Acid Receptor Subtype Function , 2009, ChemMedChem.

[22]  L. Neckers,et al.  Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins. , 2000, Journal of the National Cancer Institute.

[23]  B. Blagg,et al.  Hsp90 inhibition: elimination of shock and stress. , 2010, Bioorganic & medicinal chemistry letters.

[24]  B. Blagg,et al.  Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery. , 2006, Organic letters.

[25]  D. Solit,et al.  Development and application of Hsp90 inhibitors. , 2008, Drug discovery today.

[26]  Hong Zhang,et al.  Targeting multiple signal transduction pathways through inhibition of Hsp90 , 2004, Journal of Molecular Medicine.

[27]  B. Blagg,et al.  A library of noviosylated coumarin analogues. , 2007, Journal of Organic Chemistry.

[28]  A. Brossi,et al.  Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues. , 2010, Journal of medicinal chemistry.

[29]  G. Morgant,et al.  Synthetic Studies on Cyathin Terpenoids: Enantioselective Synthesis of the Tricyclic Core of Cyathin through Intramolecular Heck Cyclisation , 2006 .

[30]  Xiao Ming Yu,et al.  Hsp90 inhibitors identified from a library of novobiocin analogues. , 2005, Journal of the American Chemical Society.

[31]  M. Gaitanou,et al.  A Critical Role for HSP90 in Cancer Cell Invasion Involves Interaction with the Extracellular Domain of HER-2* , 2008, Journal of Biological Chemistry.

[32]  E. ROTHSTEIN,et al.  Organic Reactions , 1966, Nature.

[33]  L. Neckers,et al.  The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone* , 2000, The Journal of Biological Chemistry.

[34]  B. Blagg,et al.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. , 2008, Current medicinal chemistry.

[35]  Xiao Ming Yu,et al.  Synthesis of mono- and dihydroxylated furanoses, pyranoses, and an oxepanose for the preparation of natural product analogue libraries. , 2005, The Journal of organic chemistry.

[36]  Katerina Sidera,et al.  Extracellular HSP90: Conquering the cell surface , 2008, Cell cycle.

[37]  L. Neckers,et al.  Targeting the Molecular Chaperone Heat Shock Protein 90 Provides a Multifaceted Effect on Diverse Cell Signaling Pathways of Cancer Cells , 2007, Clinical Cancer Research.

[38]  B. Iglewski,et al.  Novel synthetic analogs of the Pseudomonas autoinducer. , 1999, Bioorganic & medicinal chemistry letters.

[39]  B. Blagg,et al.  The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity. , 2008, The Journal of organic chemistry.

[40]  Xiao Ming Yu,et al.  Synthesis of (-)-noviose from 2,3-O-isopropylidene-D-erythronolactol. , 2004, The Journal of organic chemistry.

[41]  Roman Àrvai,et al.  Total synthesis of (+/-)-vertine with Z-selective RCM as a key step. , 2010, Chemical communications.

[42]  D. Mok,et al.  Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90 , 2006, Journal of Biological Chemistry.